Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-016347
Date:2023-03-01
Issuer: HORIZON THERAPEUTICS PUBLIC LTD CO (HZNP)
Original Submission Date:

Reporting Person:

CLAYTON SEAN M.
C/O HORIZON THERAPEUTICS PLC
70 ST. STEPHEN'S GREEN DUBLIN, L2 D02 E2X4

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2023-03-01 M 14,129 a $0.00 14,408 direct
ORDINARY SHARES 2023-03-01 F 7,032 d $110.34 7,376 direct
ORDINARY SHARES 2023-03-01 0 $0.00 745 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2023-03-01 deemed execution date M 14,129 (a) ordinary shares 14,129 $0.00 28,258 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one ordinary share of the issuer.
f2 includes 279 ordinary shares of the issuer acquired by the reporting person on december 1, 2022 pursuant to an employee stock purchase program.
f3 the shares are held by the clayton family trust, of which the reporting person is the co-trustee and beneficiary.
f4 the shares subject to the restricted stock units vest 1/3rd annually on each anniversary of march 1, 2022.

Elevate your investments